IARC Monographs Volume 100E
Smokeless Tobacco

Supplementary Web Tables, Section 2, Cancer in Humans

  These web tables formed part of the original submission and have been peer reviewed. They
  are posted as supplied by the Working Group. Readers are requested to report any errors to:
  edit-vol100E@iarc.fr.
Table 2.1   Cohort studies of smokeless tobacco and cancers of the oral cavity and pharynx
Table 2.2   Case–control studies of smokeless tobacco and cancers of the oral cavity and pharynx, adjusting for tobacco smoking or among non-smokers
Table 2.3   Meta-analysis based on estimates among non-smokers or smoking-adjusted from cohort and case–control studies of oral use of ever use of smokeless tobacco and oral cancer in the USA and northern Europe
Table 2.4   Meta-analysis of smokeless tobacco use and oral and pharyngeal cancer
Table 2.5   Cross-sectional and case–control studies of smokeless tobacco and precancerous lesions of the oral cavity adjusting for tobacco smoking or among non-smokers
Table 2.6   Cohort studies of persistence of oral lesions or progression of oral lesions to cancers of the oral cavity and pharynx among smokeless tobacco users
Table 2.7   Cohort studies of smokeless tobacco and oesophageal cancer
Table 2.8   Case–control studies of smokeless tobacco and oesophageal cancer
Table 2.9    Meta-analysis based on cohort and case–control studies of oral use of smokeless tobacco and oesphageal cancer in the USA and northern Europe
Table 2.10 Meta-analysis based on cohort and case-control studies of oral use of smokeless tobacco and oesophageal cancer
Table 2.11 Case–control studies of smokeless tobacco and pancreatic cancer
Table 2.12  Cohort studies of smokeless tobacco and pancreatic cancer
Table 2.13  Cohort studies of smokeless tobacco and cancer
Table 2.14  Case–control studies of use of smokeless tobacco and cancer at other sites
Table 2.15  Case–control studies of nasal use of smokeless tobacco and cancers of the oral cavity and pharynx